HPV vaccine hesitancy
Conditions
Interventions
Control group:Let participates read the control group information
Intervention group 1:Respondents were given control group information and highlighted HPV vaccine safety information
Intervention group 2:Respondents were given control group information and information highlighting the benefits to the individual following vaccination
intervention group 3:Respondents were given control group information and information highlighting the benefits to the group following vaccination
Sponsors
Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
9 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. Volunteers to participate in the study and signs an informed consent form; 2. Have a daughter aged 9-14 years old who has not been vaccinated against HPV; 3. Reside in mainland China.
Exclusion criteria
Exclusion criteria: 1. Not a guardian of a girl aged 9-14 years old; 2. Has already received at least one dose of HPV vaccine for their daughter; 3. Persons who are currently participating in other clinical trials or similar studies; 4. Persons who refuse or are unable to collect demographic and vaccination information; 5. Persons whose daughter is a patient with contraindications to vaccination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaccine hesitancy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Willing to pay; | — |
Countries
China
Contacts
Public ContactChang Jie
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University
Outcome results
None listed